It’s time to rethink peer review policies—and consider an “Earth Shot Program”

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

At a recent NIH study section that I chaired, we had many applications that we reviewed as a group before the meeting. At the meeting, we were required to discuss over 50% of the grants.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Wafik S. El-Deiry, MD, PhD, FACP
Director, Joint Program in Cancer Biology, Brown University and Lifespan Cancer Institute
Associate Dean, Oncologic Sciences, Warren Alpert Medical School, Brown University
American Cancer Society Research Professor

YOU MAY BE INTERESTED IN

Credit: Jonah Elkowitz/ShutterstockThat President Biden was diagnosed with prostate cancer is certainly unfortunate news, but it should come as no surprise. One in eight men in the U.S. will be told they have prostate cancer at some point in their lifetime: more than 300,000 new diagnoses occur annually, and the absolute numbers are rising. 
Wafik S. El-Deiry, MD, PhD, FACP
Director, Joint Program in Cancer Biology, Brown University and Lifespan Cancer Institute
Associate Dean, Oncologic Sciences, Warren Alpert Medical School, Brown University
American Cancer Society Research Professor

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login